SciELO - Scientific Electronic Library Online

vol.32 issue4Probiotic supplement (Lactobacillus acidophilus and bulgaricus) utility in the treatment of irritable bowel syndromeVirological breakthrough in treating hepatitis B with entecavir: It means resistance? author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Revista de Gastroenterología del Perú

Print version ISSN 1022-5129


BULEJE S, José; YABAR B, Alejandro; GUEVARA-FUJITA, María  and  FUJITA, Ricardo. Molecular and genetic features of gastrointestinal stromal tumors (GIST). Rev. gastroenterol. Perú [online]. 2012, vol.32, n.4, pp.394-399. ISSN 1022-5129.

Gastrointestinal stromal tumors (GISTs) are mesenchymal neoplasms typically arising in the stomach, small intestine, colon, and other sites in the abdominal cavity and its identification has improved dramatically mainly due to better criteria in its detection. Most GISTs tumors harbor activating mutations in the tyrosine kinase receptor c-KIT or platelet derived growth factor receptor-alpha (PDGFRA). Those mutations are restricted to a few regions corresponding to important functional domains of c-KIT or PDGFRA. Upto 70% of cases are due to mutations in exon 11 of c-KIT corresponding to its juxtamembrane region of the receptor. The location and type of mutation will differentially determine the development of the disease, its prognosis and the response to inhibitors of tyrosine kinases as Imanatib. For this reason, genotyping c-KIT and PDGFRA is important for GIST diagnosis and assessment of sensitivity to tyrosine kinase inhibitors.

Keywords : Gastrointestinal stromal tumors; GIST; c-Kit; PDGFRA; Imatinib.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )